Year-End Report

FOLEY HOAG LLP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

CHAMP Act: HR 3162 S.2499 Medicare, Medicaid, and SCHIP Extension Act

LobbyistCovered position, as disclosed
THOMAS GRISSOM N/A
PAUL KIM N/A
NICK LITTLEFIELD N/A
DAVID MOHLER N/A
BARRETT THORNHILL N/A

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3162 (110th), S. 2499 (110th)

Medical/Disease Research/Clinical Labs MED

Pharmaceutical Legislation Food and Drug Administration, S 1082, HR 2900 Follow-on Biologics, S 1695

LobbyistCovered position, as disclosed
THOMAS GRISSOM N/A
PAUL KIM N/A
NICK LITTLEFIELD N/A
DAVID MOHLER N/A
BARRETT THORNHILL N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2900 (110th)

Copyright/Patent/Trademark CPT

Patent Reform, S 1145, HR 1908

LobbyistCovered position, as disclosed
THOMAS GRISSOM N/A
PAUL KIM N/A
NICK LITTLEFIELD N/A
DAVID MOHLER N/A
BARRETT THORNHILL N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.